Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer
NAR Cancer · 2026
DOI: 10.1093/narcan/zcag026 ↗Kurz gefasst
Fachartikel in der Zeitschrift NAR Cancer, 2026. Verfasst von Junhuan Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, No. 2 SEU Road, Nanj…. Hauptthemen laut MEDLINE: Breast Neoplasms, Machine Learning, Enhancer RNAs, Biomarkers, Tumor. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Undergraduate Training Programs for Innovation of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Current breast cancer biomarkers rely predominantly on protein-coding transcriptomes, leaving the regulatory information encoded by enhancer RNAs (eRNAs) largely unexploited. Here, we profiled eRNA expression across 1073 The Cancer Genome Atlas Breast Cancer (TCGA-BRCA) samples integrated with The Cancer eRNA Atlas annotations, using GTEx healthy breast tissue (n = 179) as a curated normal reference. For prognostic stratification, least absolute shrinkage and selection operator (LASSO)-Cox regression identified a 10-eRNA signature that stratified patients into high- and low-risk groups in both training (P <.0001) and independent testing cohorts (P = 0.0022), with a 3-year time-dependent area under the curve (AUC) of 0.743. Multivariate Cox analysis confirmed the signature as an independent predictor [hazard ratio = 3.176, 95% confidence interval (CI): 2.075–4.864, P <.001]. Multi-omics network integration linked these prognostic eRNAs to regulatory hubs centered on the ESR1/FOXA1/GATA3/AR axis. For early-stage detection, we developed a 19-eRNA panel via bootstrap LASSO feature selection and benchmarked ten classifiers; a Multilayer Perceptron achieved the best generalization (AUC = 0.959, 95% CI: 0.925–0.986) on an independent cohort (GSE225846). Both modules were deployed in eRNACare, a publicly accessible web application for individualized survival and tumor probability scoring. These findings establish eRNAs as a complementary noncoding layer to conventional messenger RNA classifiers, with clinical potential for breast cancer risk stratification, therapeutic guidance, and early detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, No. 2 SEU Road, Nanjing 211189, Jiangsu, China.
ORCID-Profile: Junhuan Xia, Yuting Cao, Hao Huang
Förderung
- Undergraduate Training Programs for Innovation of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Xia, J., Tian, J., Cao, Y., Zhang, S., Qian, W., Qi, Y., & Huang, H. (2026). Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer. NAR Cancer. https://doi.org/10.1093/narcan/zcag026
Vancouver
Xia J, Tian J, Cao Y, Zhang S, Qian W, Qi Y, et al. Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer. NAR Cancer. 2026. doi:10.1093/narcan/zcag026
BibTeX
@article{Xia2026,
author = {Xia, Junhuan and Tian, Jingwen and Cao, Yuting and Zhang, Suhan and Qian, Weiye and Qi, Yanan and Huang, Hao},
title = {Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer},
journal = {NAR Cancer},
year = {2026},
doi = {10.1093/narcan/zcag026}
}
EUVIMED